Importantly, despite the dramatic alterations in fatty acid and corresponding phospholipid composition, Elovl6−/− mice appear grossly normal and viable [40–42], demonstrating that ELOVL6 is not essential for the development and functioning of normal tissues, suggesting that there is a broad therapeutic window for ELOVL6 inhibition in the context of cancer treatment. This evidence concerns the gene ELOVL6 and cancer.